Regeneron Gets U.K. Authorization for Covid-19 Antibody Cocktail

By Dave Sebastian

Regeneron Pharmaceuticals Inc. said it has gotten a conditional marketing authorization from the U.K. for its antibody cocktail to treat and prevent acute Covid-19 infection.

The antibody cocktail can be used by people who may need continuing doses if they have a medical condition that makes them unlikely to be protected by vaccination, the drugmaker said Friday.

The authorizations by the U.K.'s Medicines and Healthcare Products Regulatory Agency are based on results from two Phase 3 trials, Regeneron said.

Write to Dave Sebastian at [e-mail]

(END) Dow Jones Newswires

08-20-21 0732ET